✦ LIBER ✦

Is rivaroxaban associated with lower inpatient costs compared to warfarin among patients with non-valvular atrial fibrillation?

✍ Scribed by Laliberté, François; Pilon, Dominic; Raut, Monika K.; Nelson, Winnie W.; Olson, William H.; Germain, Guillaume; Schein, Jeff R.; Lefebvre, Patrick

Book ID: 125468014
Publisher: Informa plc
Year: 2014
Tongue: English
Weight: 373 KB
Volume: 30
Category: Article
ISSN: 0300-7995
DOI: 10.1185/03007995.2014.916159

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of rivaroxaban compa

Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AF

✍ Jones, W. S.; Hellkamp, A. S.; Halperin, J.; Piccini, J. P.; Breithardt, G.; Sin 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 290 KB

For people with non-valvular atrial fibr

For people with non-valvular atrial fibrillation rivaroxaban is non-inferior to warfarin for preventing stroke or embolism, with no difference in the risk of clinically relevant bleeding

✍ Sherwood, M.; Piccini, J. P. 📂 Article 📅 2012 🏛 BMJ Publishing Group 🌐 English ⚖ 68 KB

Rivaroxaban versus warfarin in Japanese

Rivaroxaban versus warfarin in Japanese patients with non-valvular atrial fibrillation in relation to hypertension: a subgroup analysis of the J-ROCKET AF trial

✍ Matsumoto, Masayasu; Hori, Masatsugu; Tanahashi, Norio; Momomura, Shin-ichi; Uch 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 302 KB

Estimated medical cost reductions associ

Estimated medical cost reductions associated with use of novel oral anticoagulants vs warfarin in a real-world non-valvular atrial fibrillation patient population

✍ Amin, Alpesh; Stokes, Michael; Makenbaeva, Dinara; Wiederkehr, Daniel; Wu, Ning; 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 166 KB